These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 24172787)

  • 1. What is the most effective tool for detecting prostate cancer using a standard MR scanner?
    Osugi K; Tanimoto A; Nakashima J; Shinoda K; Hashiguchi A; Oya M; Jinzaki M; Kuribayashi S
    Magn Reson Med Sci; 2013 Dec; 12(4):271-80. PubMed ID: 24172787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging.
    Hoeks CM; Hambrock T; Yakar D; Hulsbergen-van de Kaa CA; Feuth T; Witjes JA; Fütterer JJ; Barentsz JO
    Radiology; 2013 Jan; 266(1):207-17. PubMed ID: 23143029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between T2 relaxation and apparent diffusion coefficient in malignant and non-malignant prostate regions and the effect of peripheral zone fractional volume.
    Simpkin CJ; Morgan VA; Giles SL; Riches SF; Parker C; deSouza NM
    Br J Radiol; 2013 Apr; 86(1024):20120469. PubMed ID: 23426849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of a combined approach of t1-weighted, t2-weighted, dynamic contrast-enhanced, and diffusion-weighted imaging in prostate cancer.
    Min BD; Kim WT; Cho BS; Kim YJ; Yun SJ; Lee SC; Kim WJ
    Korean J Urol; 2012 Dec; 53(12):830-5. PubMed ID: 23301126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric MRI for Suspected Recurrent Prostate Cancer after HIFU:Is DCE still needed?
    Lotte R; Lafourcade A; Mozer P; Conort P; Barret E; Comperat E; Ezziane M; de Guibert PJ; Tavolaro S; Belin L; Boudghene F; Lucidarme O; Renard-Penna R
    Eur Radiol; 2018 Sep; 28(9):3760-3769. PubMed ID: 29633004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interest of diffusion-weighted and gadolinium-enhanced dynamic MR sequences for the diagnosis of parotid gland tumors.
    Lechner Goyault J; Riehm S; Neuville A; Gentine A; Veillon F
    J Neuroradiol; 2011 May; 38(2):77-89. PubMed ID: 20542568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triexponential function analysis of diffusion-weighted MRI for diagnosing prostate cancer.
    Ueda Y; Takahashi S; Ohno N; Kyotani K; Kawamitu H; Miyati T; Aoyama N; Ueno Y; Kitajima K; Kawakami F; Okuaki T; Tsukamoto R; Yanagita E; Sugimura K
    J Magn Reson Imaging; 2016 Jan; 43(1):138-48. PubMed ID: 26119033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multireader Exploratory Evaluation of Individual Pulse Sequence Cancer Detection on Prostate Multiparametric Magnetic Resonance Imaging (MRI).
    Gaur S; Harmon S; Gupta RT; Margolis DJ; Lay N; Mehralivand S; Merino MJ; Wood BJ; Pinto PA; Shih JH; Choyke PL; Turkbey B
    Acad Radiol; 2019 Jan; 26(1):5-14. PubMed ID: 29705281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body MRI including diffusion-weighted imaging (DWI) for patients with recurring prostate cancer: technical feasibility and assessment of lesion conspicuity in DWI.
    Eiber M; Holzapfel K; Ganter C; Epple K; Metz S; Geinitz H; Kübler H; Gaa J; Rummeny EJ; Beer AJ
    J Magn Reson Imaging; 2011 May; 33(5):1160-70. PubMed ID: 21509875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition zone prostate cancer: revisiting the role of multiparametric MRI at 3 T.
    Rosenkrantz AB; Kim S; Campbell N; Gaing B; Deng FM; Taneja SS
    AJR Am J Roentgenol; 2015 Mar; 204(3):W266-72. PubMed ID: 25714311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Weighted Diffusion Subtraction for Detection of Clinically Significant Prostate Cancer.
    Sato T; Isoda H; Fujimoto K; Furuta A; Fujimoto M; Ito K; Kobayashi T; Nakamoto Y
    J Magn Reson Imaging; 2021 Dec; 54(6):1979-1988. PubMed ID: 34085328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
    Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
    Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of central gland prostate cancer from benign prostatic hyperplasia using monoexponential and biexponential diffusion-weighted imaging.
    Liu X; Zhou L; Peng W; Wang C; Wang H
    Magn Reson Imaging; 2013 Oct; 31(8):1318-24. PubMed ID: 23791546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Added value of diffusion-weighted MRI in detection of cervical cancer recurrence: comparison with morphologic and dynamic contrast-enhanced MRI sequences.
    Lucas R; Lopes Dias J; Cunha TM
    Diagn Interv Radiol; 2015; 21(5):368-75. PubMed ID: 26200480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of apparent diffusion coefficient and MR volumetry as independent associative factors for extra-prostatic extension (EPE) in prostatic carcinoma.
    Lim C; Flood TA; Hakim SW; Shabana WM; Quon JS; El-Khodary M; Thornhill RE; El Hallani S; Schieda N
    J Magn Reson Imaging; 2016 Mar; 43(3):726-36. PubMed ID: 26303719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative diffusion-weighted imaging and dynamic contrast-enhanced characterization of the index lesion with multiparametric MRI in prostate cancer patients.
    Yuan Q; Costa DN; Sénégas J; Xi Y; Wiethoff AJ; Rofsky NM; Roehrborn C; Lenkinski RE; Pedrosa I
    J Magn Reson Imaging; 2017 Mar; 45(3):908-916. PubMed ID: 27442039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of T2-Weighted Imaging, DWI, and Dynamic Contrast-Enhanced MRI for Calculation of Prostate Cancer Index Lesion Volume: Correlation With Whole-Mount Pathology.
    Sun C; Chatterjee A; Yousuf A; Antic T; Eggener S; Karczmar GS; Oto A
    AJR Am J Roentgenol; 2019 Feb; 212(2):351-356. PubMed ID: 30540213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study.
    Ginsburg SB; Algohary A; Pahwa S; Gulani V; Ponsky L; Aronen HJ; Boström PJ; Böhm M; Haynes AM; Brenner P; Delprado W; Thompson J; Pulbrock M; Taimen P; Villani R; Stricker P; Rastinehad AR; Jambor I; Madabhushi A
    J Magn Reson Imaging; 2017 Jul; 46(1):184-193. PubMed ID: 27990722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.